Abstract Number: 520 • 2018 ACR/ARHP Annual Meeting
Factors Associated with the Developement of Severe Respiratory Infections in Patients with Rheumatoid Arthritis Included in a Vaccination Program
Background/Purpose: Rheumatoid arthritis(RA) patients are at increased risk of infections particularly respiratory infections. These may be augmented due to RA itself and to immunosuppressive durgs,…Abstract Number: 521 • 2018 ACR/ARHP Annual Meeting
The Lung in an English Cohort of Rheumatoid Arthritis Patients – an Overview of Different Types of Involvement and Treatment
Background/Purpose: Lung disease is described in 5–20% of pts (pts) with RA and affects parenchyma, pleura, airways and vasculature; drug-induced pulmonary disease also occurs. It…Abstract Number: 522 • 2018 ACR/ARHP Annual Meeting
Analysis of Sequential Development of Pulmonary Lesions in Patients with Rheumatoid Arthritis
Background/Purpose: We previously reported that there was patterns of coexistence of pulmonary lesions and airway disease (AD) were common abnormities of patients with pulmonary involvement.…Abstract Number: 523 • 2018 ACR/ARHP Annual Meeting
The Prevalence and Clinical Characteristics of Rheumatoid Arthritis with Interstitial Lung Disease in the San Joaquin Valley of Central California
Background/Purpose: Rheumatoid Arthritis (RA) is an autoimmune disease of systemic inflammation primarily involving the small synovial joints. Approximately 1.5 million adults in the United States…Abstract Number: 524 • 2018 ACR/ARHP Annual Meeting
Clinical Course of Interstitial Lung Disease in Rheumatoid Arthritis Patients in Clinical Practice
Background/Purpose: Interstitial lung disease (ILD) is the extra-articular manifestation that most frequently worsens the course of Rheumatoid arthritis (RA) disease. Purpose: To describe the characteristics…Abstract Number: 525 • 2018 ACR/ARHP Annual Meeting
Low Interstitial Lung Disease Event Rate in Patients with Rheumatoid Arthritis: Pooled Post Hoc Analysis of Data from the Tofacitinib Clinical Development Program
Background/Purpose: Tofacitinib is an oral Janus kinase inhibitor for the treatment of RA. Interstitial lung disease (ILD) is a common extra-articular manifestation of RA,1 and…Abstract Number: 526 • 2018 ACR/ARHP Annual Meeting
Bronchiectasis in RA Is a Crucial Risk Factor of Hospitalised Pneumonia Associated with Bdmards As Well As Interstitial Lung Disease
Background/Purpose: Interstitial lung disease (ILD) is a risk factor of pneumonia in RA patients treated with biological DMARDs (bDMARDs) [1-4]. Bronchiectasis (BE) is a well-known…Abstract Number: 527 • 2018 ACR/ARHP Annual Meeting
Long-Term Follow up of Subclinical Interstitial Lung Disease in Rheumatoid Arthritis
Background/Purpose: Using of high-resolution computed tomography(HRCT) has increased the early detection of interstitial lung disease(ILD) in asymptomatic and undiagnosed individuals. This study was to identify…Abstract Number: 528 • 2018 ACR/ARHP Annual Meeting
Progression in Interstitial Lung Disease – Comparison of Rheumatoid Arthritis with Idiopathic Pulmonary Fibrosis
Background/Purpose: Rheumatoid Arthritis (RA) is a common autoimmune condition characterised by symmetrical inflammatory small joint polyarthropathy and loss of function. Systemic manifestations of RA are…Abstract Number: 529 • 2018 ACR/ARHP Annual Meeting
Chest Computed Tomography Abnormalities in Patients with Rheumatoid Arthritis By Serologic Status
Background/Purpose: Lung involvement in rheumatoid arthritis (RA) has been recognized as an important contributor to morbidity and mortality. While interstitial lung disease (ILD) is a…Abstract Number: 530 • 2018 ACR/ARHP Annual Meeting
RA-Voice: Evaluating Laryngeal Involvement in Rheumatoid Arthritis Patients
Background/Purpose: Laryngeal involvement is not uncommon in connective tissue diseases including Rheumatoid Arthritis (RA). Its prevalence has been estimated between 5% and 70% of patients…Abstract Number: 531 • 2018 ACR/ARHP Annual Meeting
Association of Rheumatoid Arthritis and Other Autoinmune Diseases
Background/Purpose: The coexistence of different autoimmune diseases (AID) has been well established in the literature. In our knowledge, there is no study assessing specifically the…Abstract Number: 532 • 2018 ACR/ARHP Annual Meeting
Relationship between Insulin Sensitivity and Beta Cell Secretion in Non-Diabetic Rheumatoid Arthritis Subjects
Background/Purpose: In non-diabetic healthy individuals insulin secretion and insulin sensitivity are linked by a negative feedback loop characterized by a hyperbolic function. We aimed to…Abstract Number: 533 • 2018 ACR/ARHP Annual Meeting
Association between Inflammation and Changes in Kidney Function in Patients with Early Rheumatoid Arthritis
Background/Purpose: One of the most severe visceral manifestations of RA is nephropathy. The key symptoms of renal dysfunction (RD) are microalbuminuria (MA), β-2-microglobulinuria (β-2M), reduced…Abstract Number: 534 • 2018 ACR/ARHP Annual Meeting
Increased Insulin Resistance and Impaired Beta-Cell Function in Patients with Rheumatoid Arthritis: The Role of Glucocorticoid Therapy?
Background/Purpose: Increased insulin resistance and impaired β-cell function have been demonstrated in rheumatoid arthritis (RA). The aim of the study was to analyze the association…
ACR Meeting Abstracts